Insiders Kymera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
34.26 ^USD	+3.94%		+8.56%	+34.56%

Jun. 01	Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting	CI
May. 22	Kymera Therapeutics, Inc. Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting	CI

Kymera Therapeutics, Inc. Appoints Felix J. Baker to the Board	Apr. 01	CI
Kymera Therapeutics Insider Sold Shares Worth $14,912,376, According to a Recent SEC Filing	Mar. 14	MT
Kymera Therapeutics Insider Sold Shares Worth $300,470, According to a Recent SEC Filing	Jan. 24	MT
Kymera Therapeutics Appoints Jeremy Chadwick COO	23-05-22	MT
Kymera Appoints Jeremy Chadwick as Chief Operating Officer	23-05-22	CI
Kymera Therapeutics, Inc. Announces Departure of Elaine Caughey as Chief Business Officer	23-02-27	CI
Insider Sell: Kymera Therapeutics	23-01-17	MT
Kymera Therapeutics, Inc. Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary	23-01-04	CI
Insider Sell: Kymera Therapeutics	22-12-16	MT
Insider Sell: Kymera Therapeutics	22-11-04	MT
Kymera Therapeutics, Inc. Announces Management Changes	22-11-03	CI
Insider Sell: Kymera Therapeutics	22-11-02	MT
Kymera Therapeutics, Inc. Appoints Leigh Morgan to its Board of Directors	22-07-08	CI
Kymera Therapeutics, Inc. Announces Executive Change	22-04-11	CI
Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Directors	22-01-18	CI
Insider Sell: Kymera Therapeutics	22-01-13	MT
Kymera Therapeutics, Inc. Appoints Vijay Sabesan as Senior Vice President, Technical Operations	21-12-06	CI
Insider Sell: Kymera Therapeutics	21-11-03	MT
Insider Sell: Kymera Therapeutics	21-10-12	MT
Kymera Therapeutics : Chief Scientific Officer Chesworth to Depart Next Month -- Shares Drop in Late Hours Trading	21-09-16	MT

No results for this search